Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 44:38-43, doi:10.1016/j.jacc.2004.03.041
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taher, T.
Right arrow Articles by Armstrong, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taher, T.
Right arrow Articles by Armstrong, P. W.

Aborted myocardial infarction in patients with ST-segment elevation

Insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy

Taha Taher, MD*, Yuling Fu, MD*, Galen S. Wagner, MD{dagger}, Shaun G. Goodman, MD{ddagger}, Claudio Fresco, MD§, Christopher B. Granger, MD{dagger}, Lars Wallentin, MD||, Frans Van de Werf, MD, Freek Verheugt, MD|| and Paul W. Armstrong, MD*,*

* University of Alberta, Edmonton, Alberta, Canada
{dagger} Duke Clinical Research Institute, Durham, North Carolina, USA
{ddagger} Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
§ Hospital S. Maria della Misericordi, Udine, Italy
|| University Hospital Gasthuisber, Leuven, Belgium
University Medical Center St. Radboud, Nijmegen, The Netherlands



View larger version (24K):

[in a new window]
 
Figure 1 Identification of aborted myocardial infarction (MI) and masquerading MI from Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 trial. CK = creatine kinase; ECG = electrocardiogram; ULN = upper limit of normal.

 


View larger version (22K):

[in a new window]
 
Figure 2 Rate of aborted myocardial infarction (MI) according to time from symptom onset to treatment. p < 0.001 for trend comparison.

 


View larger version (24K):

[in a new window]
 
Figure 3 ST-segment resolution at 60 and 180 min. p < 0.001 for trend comparison within each time point. Numbers represent percentage of patients in that category. Dark gray bars = <30% ST-segment resolution; light gray bars = 30% to 70% ST-segment resolution; white bars = ≥70% ST-segment resolution. MI = myocardial infarction.

 


View larger version (28K):

[in a new window]
 
Figure 4 Clinical outcomes of aborted myocardial infarction (MI) patients according to extent of 60-min ST-segment resolution. *p = 0.002 for comparison between groups. White bars = aborted MI with ≥70 ST-segment resolution at 60 min (n = 300); gray bars = aborted MI with <70% ST-segment resolution at 60 min (n = 239).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement